News

Article

Teligent Breaks Ground on Manufacturing and R&D Expansion

Teligent is expanding its manufacturing and R&D complex in New Jersey.

Teligent, a New Jersey-based specialty generic-drug pharmaceutical company, held a formal groundbreaking ceremony for the ongoing expansion of its manufacturing and research and development complex in Buena, NJ, the company said in a July 6, 2016 press release. The $45–50 million project will increase the facility's footprint by more than 75,000 ft2, a 200% increase to current operations. Once completed, the expansion will include the installation of a new isolator-based sterile injectable manufacturing suite and will deliver a significant increase to the company's manufacturing capacity for topical pharmaceutical products.

''We are making very good progress on our expansion, and this ceremony was an opportunity to celebrate what we are building together,'' commented Teligent's president and CEO, Jason Grenfell-Gardner, in the press release. ''We continue to be on track for project completion by the end of 2017.''

Source: Teligent

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content